Histone lactylation-induced USP33 upregulation promotes TRAF2 stabilization and scleral remodeling in form-deprivation myopia

Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. We analyzed GEO dataset GSE280609 from myopic guinea‑pig sclera. Four‑week‑old male C57BL/6J mice were used for the form‑deprivation myopia (FDM) model, and human scleral fibroblasts (HSFs) were exposed to hypoxia. USP33 was modulated by shRNA or overexpression constructs. Scleral phenotypes, protein interaction, ubiquitination, H3K18la at the USP33 promoter, and quercetin (QE) efficacy were assessed using multiple cellular and molecular assays. USP33 was significantly upregulated in myopic sclera and hypoxic HSFs, correlating with enhanced NF-κB-driven inflammation. USP33 knockdown alleviated hypoxia-induced cell injury, myofibroblast activation, ECM remodeling and inflammatory responses in HSFs, while AAV-mediated USP33 knockdown in FDM mice mitigated myopic refractive shift, scleral thinning, collagen loss and inflammation. Mechanistically, USP33 directly bound to TRAF2 via its DUSP1 domain and stabilized TRAF2 protein through K48-linked deubiquitination. Upstream, hypoxia enhanced glycolysis and lactate accumulation, which promoted H3K18 histone lactylation at the USP33 promoter and transcriptionally upregulated USP33. QE suppressed the glycolysis-H3K18la-USP33 axis and alleviated HSF dysfunction and FDM progression, effects that were reversed by USP33 overexpression. However, without axial length and corneal curvature measurements, the observed refractive changes cannot be solely attributed to axial elongation. In the FDM mouse model, histone lactylation-driven USP33 upregulation promotes scleral inflammation and remodeling, correlating with myopic refractive shifts; TRAF2 is identified as a candidate USP33 substrate, and QE targeting the glycolysis-H3K18la-USP33 axis represents a preclinical therapeutic candidate.

Authors

Institutions

Publication Details

Journal
Biology Direct
Published
2026-11-18
DOI
https://doi.org/10.1186/s13062-026-01064-z
Primary Topic
Ophthalmology and Visual Impairment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Histone lactylation-induced USP33 upregulation promotes TRAF2 stabilization and scleral remodeling in form-deprivation myopia

Boyong Zhang, Meng Guan, Jianhua Li, Jianmei Cha et al.
2 links
Biology Direct
Ophthalmology and Visual Impairment Studies
article

Histone lactylation-induced USP33 upregulation promotes TRAF2 stabilization and scleral remodeling in form-deprivation myopia

Boyong Zhang, Meng Guan, Jianhua Li, Jianmei Cha, Yuanyuan Wang
article en

Abstract

Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. We analyzed GEO dataset GSE280609 from myopic guinea‑pig sclera. Four‑week‑old male C57BL/6J mice were used for the form‑deprivation myopia (FDM) model, and human scleral fibroblasts (HSFs) were exposed to hypoxia. USP33 was modulated by shRNA or overexpression constructs. Scleral phenotypes, protein interaction, ubiquitination, H3K18la at the USP33 promoter, and quercetin (QE) efficacy were assessed using multiple cellular and molecular assays. USP33 was significantly upregulated in myopic sclera and hypoxic HSFs, correlating with enhanced NF-κB-driven inflammation. USP33 knockdown alleviated hypoxia-induced cell injury, myofibroblast activation, ECM remodeling and inflammatory responses in HSFs, while AAV-mediated USP33 knockdown in FDM mice mitigated myopic refractive shift, scleral thinning, collagen loss and inflammation. Mechanistically, USP33 directly bound to TRAF2 via its DUSP1 domain and stabilized TRAF2 protein through K48-linked deubiquitination. Upstream, hypoxia enhanced glycolysis and lactate accumulation, which promoted H3K18 histone lactylation at the USP33 promoter and transcriptionally upregulated USP33. QE suppressed the glycolysis-H3K18la-USP33 axis and alleviated HSF dysfunction and FDM progression, effects that were reversed by USP33 overexpression. However, without axial length and corneal curvature measurements, the observed refractive changes cannot be solely attributed to axial elongation. In the FDM mouse model, histone lactylation-driven USP33 upregulation promotes scleral inflammation and remodeling, correlating with myopic refractive shifts; TRAF2 is identified as a candidate USP33 substrate, and QE targeting the glycolysis-H3K18la-USP33 axis represents a preclinical therapeutic candidate.

Biology Direct
Kunming Medical University (CN), First Affiliated Hospital of Kunming Medical University (CN)
Good health and well-being
Ophthalmology and Visual Impairment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon